SCHEMBL30548907

SCHEMBL30548907

Cc1cc(OCc2ccccc2)c(C)c(C)c1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
MAPK1 P28482 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1A P08908 2/20 0.45
ADRA1D P25100 2/20 0.45
ADRA1A P35348 2/20 0.45
ADRA1B P35368 2/20 0.45
FFAR4 Q5NUL3 1/20 0.45
PTPN1 P18031 1/20 0.45
MAOB P27338 3/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CDK4 P11802 1/20 0.44
CCNB1 P14635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8758871 1.00 MAPT (0.51) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL698534 0.87 MAPT (0.48) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL16095685 0.87 MAPT (0.52) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL31638951 0.87 MAPT (0.51) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL8761806 0.86 MAPT (0.47) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL8761770 0.85 MAPT (0.49) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL16476807 0.84 MAPT (0.45) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL14279014 0.83 MAPT (0.57) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL16097056 0.82 MAPT (0.41) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2
SCHEMBL3268751 0.81 MAPT (0.49) MAPTL3MBTL1TDP1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137071-A2 TRIESTER COMPOUNDS AND METHODS OF USE THEREOF LIFEMINE THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
WO-2025137084-A2 TRIESTER COMPOUNDS AND METHODS OF USE THEREOF LIFEMINE THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
CN-116802176-A Oxindoles and methods of use thereof 阿利戈斯治疗公司 2023-09-22 CN disclosed